AG
AGIO icon

Aperio Group’s Agios Pharmaceuticals AGIO Stock Holding History

Aperio Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$5.13M Buy
118,318
+66,669
+129% +$2.64M 0.02% 823
2020
Q3 		$1.81M Buy
51,649
+7,388
+17% +$324K 0.01% 1163
2020
Q2 		$2.37M Buy
44,261
+10,077
+29% +$467K 0.01% 1031
2020
Q1 		$1.21M Sell
34,184
-7,209
-17% -$333K 0.01% 1228
2019
Q4 		$1.98M Buy
41,393
+19,111
+86% +$722K 0.01% 1094
2019
Q3 		$722K Buy
22,282
+4,731
+27% +$196K ﹤0.01% 1566
2019
Q2 		$875K Buy
17,551
+9,705
+124% +$519K ﹤0.01% 1466
2019
Q1 		$529K Buy
7,846
+1,769
+29% +$103K ﹤0.01% 1725
2018
Q4 		$280K Buy
6,077
+2,283
+60% +$141K ﹤0.01% 1973
2018
Q3 		$293K Sell
3,794
-94
-2% -$7.56K ﹤0.01% 2022
2018
Q2 		$327K Buy
3,888
+81
+2% +$7.06K ﹤0.01% 1959
2018
Q1 		$311K Buy
+3,807
New +$294K ﹤0.01% 1940
2017
Q4 		– Sell
-4,074
Closed -$272K – 2239
2017
Q3 		$272K Buy
4,074
+72
+2% +$4.33K ﹤0.01% 1969
2017
Q2 		$206K Buy
+4,002
New +$205K ﹤0.01% 2083
2016
Q3 		– Sell
-5,572
Closed -$233K – 2063
2016
Q2 		$233K Buy
5,572
+320
+6% +$15.8K ﹤0.01% 1781
2016
Q1 		$213K Buy
+5,252
New +$225K ﹤0.01% 1841

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Aperio Group's AGIO Position: Q4 2020 in Review

Aperio Group increased its Agios Pharmaceuticals (AGIO) stake by 129% in Q4 2020, buying an estimated $2.64M and bringing the position to 118,318 shares worth $5.13M. The position accounts for 0.02% of the portfolio, ranked #823.

Aperio Group first reported a position in AGIO in Q1 2016 and has held it in 16 quarters since. 201 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • Aperio Group held 118,318 shares of Agios Pharmaceuticals worth $5.13M as of Q4 2020.
  • Aperio Group bought 66,669 Agios Pharmaceuticals shares in Q4 2020, an estimated $2.64M.
  • Agios Pharmaceuticals made up 0.02% of Aperio Group's portfolio in Q4 2020, its #823 holding.
  • Aperio Group first reported a position in Agios Pharmaceuticals in Q1 2016 and has held it in 16 quarters since.
  • 201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.